The Pharmaceutical Industry Exhibition in Shenzhen (CPHI & PMEC China) continues to focus on the development of the pharmaceutical industry in the Guangdong-Hong Kong-Macao Greater Bay Area, radiating the Asian market, focusing on the transformation and upgrading of new drug R&D and process technology innovation, creating a more accurate and professional, technology-driven industrial improvement platform, deeply linking the industrial cooperation and exchange between the Guangdong-Hong Kong-Macao Greater Bay Area and even Asia.

Adhering to the development strategy of立足上海,布局长三角、粤港澳,辐射全球based in Shanghai, expanding in the Yangtze River Delta and the Guangdong-Hong Kong-Macao Greater Bay Area, and radiating globally. CPHI & PMEC China will connect the global market, deepen regional exploration, tap into hot fields, and help enterprises seize opportunities, capture markets, and welcome growth.

The Guangdong-Hong Kong-Macao Greater Bay Area is one of the most open and economically vibrant regions in China. In recent years, with the support and promotion of national and local policies, the Guangdong-Hong Kong-Macao Greater Bay Area has developed into an important area for the gathering of China's biopharmaceutical industry, with a more complete industrial layout, forming a high-tech and industrial innovation base with global influence. It is expected that by 2028, the GDP of the health industry in the Guangdong-Hong Kong-Macao Greater Bay Area will reach 2 trillion yuan, and by 2030 it will reach a scale of 2.5 to 3 trillion yuan.

The Pharmaceutical Industry Exhibition in Shenzhen (CPHI & PMEC China) attracts professional audiences from 35 countries and regions around the world, providing an open and efficient procurement and communication platform for the upstream and downstream of the pharmaceutical industry, helping Chinese pharmaceutical companies accelerate their expansion into the Guangdong-Hong Kong-Macao Greater Bay Area and the Asian market.

The Pharmaceutical Industry Exhibition in Shenzhen (CPHI & PMEC China) is an important stage for pharmaceutical companies to promote their brand image and introduce new technologies and products to the world. The exhibition always leads with an international perspective, committed to helping Chinese pharmaceutical companies accelerate their integration into the global pharmaceutical innovation chain, industrial chain, and supply chain, bringing higher-quality resources and value to the pharmaceutical industry.